Membrane proteins consist of 25-30% coding genes in typical genomes and account about half of drug target in the R&D of biotech and pharmaceutical industry. In addition, membrane proteins have been shown to channel or translocate metabolites or bioactive small molecules in our bodies, which make it possible to exploit membrane proteins in both drug discovery and delivery. To do so, it is essential to know the mechanisms of target membrane proteins, and the key lies in the understanding of their structure-function relationship. In this webinar, I will discuss plans of our ongoing projects in understanding the mechanism of two medically important membrane proteins in trafficking cholesterol and RNA/DNA oligos. The first objective of this webinar is to discuss how we will utilize the knowledge through basic research of membrane proteins to enable therapeutic and pharmaceutical applications. Secondly, through this forum, we want to share our work in Canada, establish and strengthen future collaborations with Taiwanese colleagues.